Posted by Michael Wonder on 04 Jan 2019
MHRA releases response to consultation on EU exit no-deal legislative proposals
3 January 2019 - The UK is leaving the EU on 29 March 2019.
We remain focused on delivering the deal that we have negotiated with the EU. However, as a responsible government, it is right that we continue to prepare for all scenarios and provide information so that other organisations can do the same.
Following our consultation on how medicines, medical devices and clinical trials would be regulated in a no-deal scenario, we have today issued updated guidance setting out the UK’s proposed arrangements for regulation if we leave the EU on 29 March 2019 with no deal.
